On Monday Oncology Pharma Inc. stock price gained impressive 10.03%

The Oncology Pharma Inc. stock price gained 10.03% on the last trading day (Monday, 14th Jun 2021), rising from $31.81 to $35.00. , and has now gained 10 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the day the stock fluctuated 6.36% from a day low at $33.28 to a day high of $35.39. The price has risen in 9 of the last 10 days and is up by 59.16% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 23 thousand more shares were traded than the day before. In total, 476 thousand shares were bought and sold for approximately $16.66 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Oncology Pharma Inc. stock with a 90% probability to be traded between $18.29 and $38.55 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Mostly positive signals in the chart today. The Oncology Pharma Inc. stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $27.57 and $26.48. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, May 20, 2021, and so far it has risen 85.58%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 months Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

On the downside, the stock finds support just below today's level from accumulated volume at $31.81 and $30.70.There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Oncology Pharma Inc. finds support just below today's level at $31.81. If this is broken, then the next support from accumulated volume will be at $30.70 and $28.99.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $2.12 between high and low, or 6.36%. For the last week, the stock has had a daily average volatility of 8.13%.

Since the Oncology Pharma Inc. has been rising for 10 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Oncology Pharma Inc. stock to perform well in the short-term period.